Moderator: Reginald Q. Knight, MD, MS
65. A risk benefit analysis of increasing surgical invasiveness relative to frailty status in adult spinal deformity surgery
Peter G. Passias, MD1; Avery Brown, BS2; Bassel G. Diebo, MD3; Renaud Lafage, MSc4; Virginie Lafage, PhD4; Christopher P. Ames, MD5; Douglas C. Burton, MD6; Robert A. Hart, MD7; Gregory M. Mundis Jr., MD8; Brian J. Neuman, MD9; Breton Line, BS10; Christopher I. Shaffrey, MD11; Eric O. Klineberg, MD12; Justin S. Smith, MD, PhD13; Frank J. Schwab, MD4; Shay Bess, MD14; International Spine Study Group15
1NY Spine Institute, NYU Langone Health, New York, NY, US; 2Department of Orthopedic Surgery, NYU Langone Orthopedic Hospital, NYU Langone Health, New York, NY, US; 3Department of Orthopaedic Surgery, SUNY Downstate Medical Center, Brooklyn, NY, US; 4Hospital for Special Surgery, New York, NY, US; 5University of California, San Francisco, San Francisco, CA, US; 6University of Kansas Medical Center, Kansas City, KS, US; 7Swedish Neuroscience Institute, Seattle, WA, US; 8Scripps Clinic Medical Group, Department of Orthopedics, La Jolla, CA, US; 9Baltimore, MD, US; 10Denver International Spine Center, Denver, CO, US; 11University of Virginia, Charlottesville, VA, US; 12UC, Davis School of Medicine, Sacramento, CA, US; 13UVA Health System, Charlottesville, VA, US; 14Denver, CO, US; 15Brighton, CO, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
66. Preop opioid use is associated with worse postop outcomes and chronic opioid use in non-revision adult scoliosis patients: corroboration of two independent multi-center studies
Shay Bess, MD1; Breton Line, BS2; Michael P. Kelly, MD3; Christine R. Baldus, RN4; Christopher P. Ames, MD5; Douglas C. Burton, MD6; Elizabeth Yanik, PhD, MSc7; Robert K. Eastlack, MD8; Munish C. Gupta, MD9; Eric O. Klineberg, MD10; Khaled M. Kebaish, MD11; Han Jo Kim, MD12; Jeffrey L. Gum, MD13; Richard A. Hostin Jr., MD14; Gregory M. Mundis Jr., MD15; Virginie Lafage, PhD12; Frank J. Schwab, MD12; Christopher I. Shaffrey, MD16; Justin S. Smith, MD, PhD17; Keith H. Bridwell, MD18; International Spine Study Group19
1Denver, CO, US; 2Denver International Spine Center, Denver, CO, US; 3Washington University, Saint Louis, MO, US; 4Washington University, Department of Orhtopedics, St. Louis, MO, US; 5University of California, San Francisco, San Francisco, CA, US; 6University of Kansas Medical Center, Kansas City, KS, US; 7Washington University in St. Louis, St. Louis, MO, US; 8Scripps Clinic, San Diego, CA, US; 9Washington University School of Medicine, St. Louis, MO, US; 10UC, Davis School of Medicine, Sacramento, CA, US; 11Johns Hopkins University, Baltimore, MD, US; 12Hospital for Special Surgery, New York, NY, US; 13Norton Leatherman Spine Center, Louisville, KY, US; 14Southwest Scoliosis Institute, Plano, TX, US; 15Scripps Clinic Medical Group, Department of Orthopedics, La Jolla, CA, US; 16University of Virginia, Charlottesville, VA, US; 17UVA Health System, Charlottesville, VA, US; 18Washington University In St. Louis School of Medicine, Saint Louis, MO, US; 19Brighton, CO, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
67. Lateral lumbar interbody fusion with percutaneous pedicle screw fixation (llif-pps): are we getting the sagittal alignment right?
Breana Siljander, MD1; J. Alex A. Thomas, MD2; Jonathan N. Sembrano, MD3; Nicholas R. Dick, BS
1Minneapolis, MN, US; 2Atlantic Neurosurgical and Spine Spec., Wilmington, NC, US; 3University of Minnesota, Minneapolis, MN, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
68. Early patient reported-outcomes can be used to identify patients at risk for poor 1-year outcomes in adult spinal deformity
Alvaro Ibaseta, MS1; Rafa Rahman, BS2; Nicholas S. Andrade, BS1; Richard L. Skolasky, ScD3; Lee H. Riley III, MD4; David B. Cohen, MD, MPH3; Daniel M. Sciubba, MD2; Khaled M. Kebaish, MD3; Brian J. Neuman, MD1
1Baltimore, MD, US; 2Johns Hopkins University School of Medicine, Baltimore, MD, US; 3Johns Hopkins University, Baltimore, MD, US; 4Johns Hopkins Outpatient Ctr/Dept Ortho Surgery, Baltimore, MD, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
Discussion
69. Coronal correction using the kickstand rod technique: a pilot adult scoliosis study and analysis of early outcomes and complications
Thomas Buell, MD1; Peter A. Christiansen, MD2; Avery L. Buchholz, MD, MPH3; Ching-Jen Chen, MD4; Chun-Po Yen, MD5; Mark E. Shaffrey, MD4; Christopher I. Shaffrey, MD5; Justin S. Smith, MD, PhD3
1University of Virginia Neurosurgery, Charlottesville , VA, US; 2University of Virgnia Department of Neurosurgery, Charlottesville, VA, US; 3University of Virginia Health System, Charlottesville, VA, US; 4University of Virginia Health System, Department of Neurosurgery, Charlottesville, VA, US; 5University of Virginia, Charlottesville, VA, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
70. Anterior column realignment (ACR) performed at l2-3 achieves suboptimal lumbo-pelvic realignment compared with l2 pedicle subtraction osteotomy (PSO)
Brian Dial, MD1; Amanda N. Fletcher, MD, MS2; Mostafa A. Gabr, MD, CCRP, MHS1; Anthony Catanzano, MD2; Melissa Erickson, MD2; C. Rory Goodwin, MD, PhD2; Isaac O. Karikari, MD2
1Duke University, Durham, NC, US; 2Duke University Medical Center, Durham, NC, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
71. High preoperative t1 slope is a marker for global sagittal malalignment
Ethan W. Ayres, MPH1; Dainn Woo, BS1; Dennis Vasquez-Montes, MS, BA1; Avery Brown, BS1; Haddy Alas, BS1; Edem J. Abotsi, BA1; Christopher Varlotta, BS1; Cole Bortz, BA2; Erik Wang, BA1; Katherine E. Pierce, BS2; Michael Smith, MD2; Yong H. Kim, MD1; Aaron J. Buckland, MBBS, FRACS1; Themistocles S. Protopsaltis, MD1
1Department of Orthopedic Surgery, NYU Langone Orthopedic Hospital, NYU Langone Health, New York, NY, US; 2New York, NY, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
72. Operation timing affects outcomes after adult spinal deformity surgery
Tina Raman, MD1; Igor Dolgalev, MS1; Thomas J. Errico, MD2
1New York, NY, US; 2Center for Spinal Disorders, Orthopedic Surgery, Nicklaus Children’s Hospital, Miami, FL, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
73. Tranexamic acid in patients undergoing adult spinal deformity surgery
Tina Raman, MD1; Aaron J. Buckland, MBBS, FRACS2; Christopher Varlotta, BS2; Peter G. Passias, MD3; Thomas J. Errico, MD4
1New York, NY, US; 2Department of Orthopedic Surgery, NYU Langone Orthopedic Hospital, NYU Langone Health, New York, NY, US; 3NY Spine Institute, NYU Langone Health, New York, NY, US; 4Center for Spinal Disorders, Orthopedic Surgery, Nicklaus Children’s Hospital, Miami, FL, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
Discussion